Position history for Merit Financial Group, LLC's holdings in ImmunityBio, Inc.
Merit Financial Group, LLC holds 44,308 shares of IBRX (ImmunityBio, Inc.), worth $87,730 as of 2025-Q4. The position was decreased (-1.6% shares). IBRX represents 0.0% of Merit Financial Group, LLC's portfolio.
Current Value
$87,730
Current Shares
44,308
Total Value Change
-$313,150
Total Shares Change
+496
Other major holders of IBRX: BNP PARIBAS FINANCIAL MARKETS, UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC
Decreased |
| 44,308 |
-1.6% |
| $87,730 |
| 0.0% |
| $1.98 |
0 |
| 2025-Q3 | Decreased | 45,018 | -8.4% | $110,744 | 0.0% | $2.57 | 0 |
| 2025-Q2 | Increased | 49,175 | +11.2% | $129,822 | 0.0% | $2.70 | 25 |
| 2025-Q1 | Increased | 44,244 | +1.0% | $133,174 | 0.0% | $3.14 | 22 |
| 2024-Q4 | Increased | 43,809 | +0.0% | $112,151 | 0.0% | $2.68 | 22 |
| 2024-Q3 | Decreased | 43,800 | -0.0% | $162,936 | 0.0% | $3.93 | 0 |
| 2024-Q2 | Increased | 43,819 | +0.0% | $276,936 | 0.0% | $6.32 | 23 |
| 2024-Q1 | Increased | 43,812 | +0.0% | $400,880 | 0.0% | $5.37 | 24 |